Found 238 matching trials
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations PHASE2 This is a single-center, open-label, phase I clinical trial aimed to evalua...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer PHASE1 The purpose of this study is to determine safety and preliminary efficacy o...
Show More Location
University of California at San Diego Moores Cancer Center
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer PHASE2 Preoperative radiotherapy combined with 5-fluorouracil/capecitabine is curr...
Show More Learn More & Join Trial
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients PHASE2 A multicenter, prospective, open, randomized cohort, non controlled phase I...
Show More Learn More & Join Trial
Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer N/A This is a non-interventional study,aim to observe the safety and efficiency...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC NA The goal of this clinical trial is to evaluate the efficacy and safety of r...
Show More Location
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial